Pascal and Francis Bibliographic Databases

Help

Search results

Your search

kw.\*:("Carvedilol")

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Language

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 767

  • Page / 31
Export

Selection :

  • and

Validation of UV spectrophotometric and nonaqueous titration methods for the determination of carvedilol in pharmaceutical formulationsVIANA SILVA IEGGLI, Carine; GONCALVES CARDOSO, Simone; POTRICH BELLE, Luziane et al.Journal of AOAC International. 2005, Vol 88, Num 5, pp 1299-1303, issn 1060-3271, 5 p.Article

Pharmacology of carvedilolDULIN, Brian; ABRAHAM, William T.The American journal of cardiology. 2004, Vol 93, Num 9A, pp 3B-6B, issn 0002-9149, SUPArticle

Mechanisms involved in the cardiac protection efficacy of carvedilolGOUT, B; FEUERSTEIN, G. Z; BRIL, A et al.Heart failure reviews. 1999, Vol 4, Num 1, pp 29-37, issn 1382-4147Article

Carvedilol can restore the multifractal properties of heart beat dynamics in patients with advanced congestive heart failureCHIU, Kuan-Ming; CHAN, Hsiao-Lung; CHU, Shu-Hsun et al.Autonomic neuroscience : basic & clinical. 2007, Vol 132, Num 1-2, pp 76-80, issn 1566-0702, 5 p.Article

A case of drug-induced pneumonitis caused by carvedilolMARKOU, Nikolaos; ANTZOULATOS, Nikolaos; HANIOTOU, Aekaterini et al.Respiration (Basel). 2004, Vol 71, Num 6, pp 650-652, issn 0025-7931, 3 p.Article

Validated Stability-Indicating Capillary Electrophoresis Method for the Separation and Determination of a Fixed-Dose Combination of Carvedilol and Hydrochlorothiazide in TabletsALZOMAN, Nourah Z; SULTAN, Maha A; MAHER, Hadir M et al.Journal of AOAC International. 2013, Vol 96, Num 5, pp 951-959, issn 1060-3271, 9 p.Article

Effects of Carvedilol upon intra- and interventricular synchrony in patients with chronic heart failureCASTRO, Pablo F; MC-NAB, Paul; CHIONG, Mario et al.The American journal of cardiology. 2005, Vol 96, Num 2, pp 267-269, issn 0002-9149, 3 p.Article

Antiarrhythmic drug carvedilol inhibits HERG potassium channelsKARLE, Christoph A; KREYE, Volker A. W; THOMAS, Dierk et al.Cardiovascular research. 2001, Vol 49, Num 2, pp 361-370, issn 0008-6363Article

Carvedilol therapy is associated with a sustained decline in brain natriuretic peptide levels in patients with congestive heart failureFRANTZ, Robert P; OLSON, Lyle J; BAILEY, Kent R et al.The American heart journal. 2005, Vol 149, Num 3, pp 541-547, issn 0002-8703, 7 p.Article

Utilisation du carvedilol en pratique quotidienne = Use of carvedilol in daily practiceCOHEN-SOLAL, A; LOGEART, D; GUITI, C et al.Annales de cardiologie et d'angéiologie (Paris). 1999, Vol 48, Num 9-10, pp 647-651, issn 0003-3928Conference Paper

Pharmacokinetic properties of a new controlled-release formulation of carvedilolTENERO, David M; HENDERSON, Linda S; BAIDOO, Charlotte A et al.The American journal of cardiology. 2006, Vol 98, Num 7, issn 0002-9149, 5L-16L, SUPArticle

Long-term Carvedilol therapy increases parasympathetic nervous system activity in chronic congestive heart failureGOLDSMITH, R. L; BIGGER, J. T; BLOOMFIELD, D. M et al.The American journal of cardiology. 1997, Vol 80, Num 8, pp 1101-1104, issn 0002-9149Article

The adrenergic pharmacology of CarvedilolSPONER, G; FEUERSTEIN, G. Z.Heart failure reviews. 1999, Vol 4, Num 1, pp 21-27, issn 1382-4147Article

Epigallocatechin gallate, the major component of polyphenols in green tea, inhibits telomere attrition mediated cardiomyocyte apoptosis in cardiac hypertrophyRUI SHENG; GU, Zhen-Lun; XIE, Mei-Lin et al.International journal of cardiology. 2013, Vol 162, Num 3, pp 199-209, issn 0167-5273, 11 p.Article

Heart rate dynamic during an exercise test in heart failure patients with different sensibilities of the carvedilol therapy Heart rate dynamic during exercise testOLIVEIRA CARVALHO, Vitor; RODRIGUES ALVES, Rodrigo Xavier; ALCIDES BOCCHI, Edimar et al.International journal of cardiology. 2010, Vol 142, Num 1, pp 101-104, issn 0167-5273, 4 p.Article

In vivo evaluation of alginate microspheres of carvedilol for nasal deliveryPATIL, Sanjay B; KAUL, Ankur; BABBAR, Anil et al.Journal of biomedical materials research. Part B, Applied biomaterials. 2012, Vol 100, Num 1, pp 249-255, issn 1552-4973, 7 p.Article

Death and hospitalization in heart failure patients receiving carvedilol vs. metoprolol tartrateDELEA, Thomas E; STANFORD, Richard; HAGIWARA, May et al.International journal of cardiology. 2005, Vol 99, Num 1, pp 117-124, issn 0167-5273, 8 p.Article

Neutrophils superoxide anion generation during carvedilol therapy in patients with stable anginaKOWALSKI, Jan; BŁASZCZYK, Jan; PETECKA, Edyta et al.International journal of cardiology. 2005, Vol 102, Num 3, pp 397-402, issn 0167-5273, 6 p.Article

Commentary on the Carvedilol or Metoprolol European Trial (COMET)POOLE-WILSON, Philip A.The American journal of cardiology. 2004, Vol 93, Num 9A, pp 40B-42B, issn 0002-9149, SUPArticle

Proteomic profiling of cellular responses to Carvedilol enantiomers in vascular smooth muscle cells by iTRAQ-coupled 2-D LC―MS/MSMINGXUAN WANG; XIUJUAN WANG; CHING, Chi Bun et al.Journal of proteomics (Print). 2010, Vol 73, Num 8, pp 1601-1611, issn 1874-3919, 11 p.Article

Traitement par carvedilol dans l'insuffisance cardiaque en pratique libérale (initiation du traitement et suivi à un an). Etude KEOPS = Treating heart failure with carvedilol in private practice initiating treatment and follow-up at one year. The KEOPS studyKOMAJDA, M; AMOUYEL, P; JOHNSON, N et al.Archives des maladies du coeur et des vaisseaux. 2007, Vol 100, Num 10, pp 818-826, issn 0003-9683, 9 p.Article

Inhibitory effects of carvedilol on calcium channels in vascular smooth muscle cellsNAKAJIMA, Toshiaki; MA, Ji; IIDA, Haruko et al.Japanese heart journal. 2003, Vol 44, Num 6, pp 963-978, issn 0021-4868, 16 p.Article

Effect of specific ADRB1/ADRB2/AGT genotype combinations on the association between survival and carvedilol treatment in chronic heart failure: a substudy of the ECHOS trialPETERSEN, Morten; ANDERSEN, Jon T; POULSENA, Henrik E et al.Pharmacogenetics and genomics (Print). 2012, Vol 22, Num 10, pp 709-715, issn 1744-6872, 7 p.Article

Carvedilol preserves endothelial junctions and reduces myocardial no-reflow after acute myocardial infarction and reperfusionJINGLIN ZHAO; YUEJIN YANG; SHIJIE YOU et al.International journal of cardiology. 2007, Vol 115, Num 3, pp 334-341, issn 0167-5273, 8 p.Article

Carvedilol inhibits Kir2.3 channels by interference with PIP2-channel interactionFERRER, Tania; PONCE-BALBUENA, Daniela; LOPEZ-IZQUIERDO, Angélica et al.European journal of pharmacology. 2011, Vol 668, Num 1-2, pp 72-77, issn 0014-2999, 6 p.Article

  • Page / 31